Biocompatible and biodegradable gradient layer system for regenerative medicine and for tissue support
The present invention is directed to a biocompatible and preferably biodegradable gradient layer system comprising at least one set of layers comprising a biocompatible and preferably biodegradable cross-linked polymer and at least one biocompatible and preferably biodegradable support layer, wherein a gradient is preferably formed with respect to the mechanical and/or physical properties of one or more layers of the at least one set of layers comprising a biocompatible and biodegradable cross-linked polymer and/or the at least one biocompatible and preferably biodegradable support layer. The at least one support layer preferably comprises a biocompatible and preferably biodegradable meltable polymer and/or a biocompatible and incorporable material. This biocompatible and preferably biodegradable gradient layer system may be used as a biomaterial for regenerative medicine, particularly as a wound dressing or for tissue support. The present invention also provides means utilizing said inventive gradient layer system and methods for producing same.
1. A biocompatible gradient layer system comprising:
at least one biocompatible meltable support layer comprising polycaprolactone (PCL);
at least one set of layers disposed on the at least one biocompatible meltable support layer; and
a continuous fiber diameter gradient within the at least one set of layers,
wherein the at least one set of layers comprises fibers of a biocompatible and biodegradable polymer,
wherein the fibers of the biocompatible and biodegradable polymer are formed by electrospinning a solution containing crosslinkers and the biocompatible and biodegradable polymer,
wherein the fibers of the biocompatible and biodegradable polymer are selected from gelatin or collagen,
wherein the crosslinkers are selected from glyoxal or glyoxal-trimer-dihydrate,
wherein the fibers of the biocompatible and biodegradable polymer are internally crosslinked with the crosslinkers glyoxal or glyoxal-trimer-dihydrate,
wherein the fibers of the resulting biocompatible and biodegradable crosslinked polymer are loosely packed and not interconnected to each other,
wherein the continuous fiber diameter gradient is formed by crosslinking during the electrospinning process,
wherein the diameter of the polymeric fibers is increased within the at least one set of layers due to the continuous crosslinking, and
wherein the polymeric fibers of the at least one set of layers have a diameter between about 1 nm to about 50 μm.
2. The gradient layer system according to claim 1 , wherein the fiber diameter increases or decreases from about 0.0001 μm to about 1 μm per micrometer height of the set of layers either within the at least one set of layers or between several sets of layers of the gradient layer system.
3. The gradient layer system according to claim 1 , wherein the at least one biocompatible support layer comprises
an incorporable material selected from the group consisting of an incorporable ceramic material, an incorporable ceramic material made from tricalcium phosphate (TCP) and an incorporable ceramic material made from hydroxyl apatite (HA).
4. The gradient layer system according to claim 1 , wherein the at least one set of layers comprising the biocompatible and biodegradable cross-linked polymer is present in the form of a fleece, a net or a mesh-like structure.
5. The gradient layer system according to claim 1 , wherein the at least one biocompatible support layer is present in the form of bands, strands, fibers, particles, drops, a net or mesh-like structures, a sheet, a film, a foil, or a laminate.
6. The gradient layer system according to claim 1 , wherein the gradient layer system is seeded with cells.
7. The gradient layer system according to claim 6 , wherein the cells are selected from mammalian, human or non-human cells selected from committed stem cells, differentiated cells, adult stem cells, bone marrow stem cells, umbilical cord stem cells, engineered or non-engineered stem cells, primary or immortalized (cell-line) stem cells, and mesenchymal stem cells, or the cells are selected from a mixture of cells as defined before.
8. The gradient layer system according to claim 1 , wherein the gradient layer system further comprises agents selected from cytokines, interleukins, growth factors, immunoglobulins, RGD-peptides, and antibacterial agents.
9. The gradient layer system according to claim 6 , wherein the cells are selected from cartilage cells, epithelial cells, endothelial cells, endothelial cells of vascular tissue, endothelial cells of corneal tissue, skin cells, osteocytes, osteoblasts, cementoblasts, bone cells, myoblasts, neuroblasts, fibroblasts cells of all connective tissues including fibroblasts selected from gingival, skin or corneal fibroblasts, and fibroblasts selected from gingival, skin or corneal fibroblasts together with periodontal ligament fibroblasts, keratinocytes, gingival keratinocytes, glioblasts, germ cells, hepatocytes, chondrocytes, cardiac muscle cells, connective tissue cells, glial cells, hormone-secreting cells, cells of the immune system, neurons, cells of the central nervous system, neuronal cells, pericytes, myocytes, adipocytes, astrocytes, melanocytes, tissue cells, tissue cells from autologous tissue sources, tissue cells from allogenic tissue sources, tissue cells from xenogenic tissue sources, autologous cells, allogenic cells, xenogenic cells, tenocytes, cardiomyocytes, hepatocytes, and smooth muscle cells, or the cells are selected from a mixture of cells as defined before.